Peter Wang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- Single-cell and spatial transcriptomics
- Circular RNAs in diseases
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 7
-
- Ubiquitin and proteasome pathways 8
- Circular RNAs in diseases 5
- Protein Degradation and Inhibitors 3
- RNA modifications and cancer 3
- Glycosylation and Glycoproteins Research 3
- Cancer-related gene regulation 3
- Co-authors
- Wenjun Liu (6 shared papers)Guanning Shang (3 shared papers)Yuyun Li (1 shared paper)Wenyi Wei (1 shared paper)Wenxiao Jiang (1 shared paper)Xiaoming Dai (1 shared paper)Ting Chen (2 shared papers)Qiuli Chen (4 shared papers)
- Journals
- Annals of Oncology (3 papers)Frontiers in Oncology (3 papers)Seminars in Cancer Biology (3 papers)Frontiers in Immunology (3 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Peter Wang
33 papers receiving 1.5k citations
Peter Wang's Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 381
- Molecular Biology 1.1k
- Biophysics 72
- Immunology 196
- Aging 16
Countries citing papers authored by Peter Wang
This map shows the geographic impact of Peter Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wang more than expected).
Fields of papers citing papers by Peter Wang
This network shows the impact of papers produced by Peter Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wang. The network helps show where Peter Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans Hit paper breakdown → | 2022 | 691 |
| 2 | 2019 | 270 | |
| 3 | 2020 | 82 | |
| 4 | 2022 | 73 | |
| 5 | 2022 | 48 | |
| 6 | 2022 | 47 | |
| 7 | 2014 | 46 | |
| 8 | 2022 | 38 | |
| 9 | 2023 | 36 | |
| 10 | 2022 | 33 | |
| 11 | 2009 | 23 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 17 | |
| 14 | 2022 | 14 | |
| 15 | 2023 | 13 | |
| 16 | 2020 | 12 | |
| 17 | 2018 | 8 | |
| 18 | 2022 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2023 | 7 |
About Peter Wang
Peter Wang is a scholar working on Cancer Research, Molecular Biology, Oncology, Immunology and Hematology, having authored 35 papers that have together received 1.5k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (5 papers), Protein Degradation and Inhibitors (3 papers), RNA modifications and cancer (3 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer-related gene regulation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (381 citations), Molecular Biology (1.1k citations), Biophysics (72 citations), Immunology (196 citations) and Aging (16 citations). Peter Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenjun Liu, Guanning Shang, Yuyun Li, Wenyi Wei, Wenxiao Jiang, Xiaoming Dai, Ting Chen, Qiuli Chen, Jinxin Liu and Shizhe Li. Their work appears in journals such as Annals of Oncology, Frontiers in Oncology, Seminars in Cancer Biology, Frontiers in Immunology and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.